期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

体外高频热疗联合腹腔局部化疗治疗卵巢癌恶性腹水的临床疗效观察 被引量：4

下载PDF
导出
摘要 目的采用HG-2000体外高频热疗机联合腹腔局部化疗治疗卵巢癌恶性腹水的患者,评价其疗效及不良反应。方法确诊为卵巢癌合并腹水的患者40例,随机分为2组,每组20例。A组:腹腔灌注紫杉醇局部化疗联合体外高频热疗,治疗时间为60 min,每周2次,每3周重复1次,连续治疗12周。B组:单纯腹腔灌注紫杉醇局部化疗,每3周重复1次,连续治疗12周,评价两组患者疗效及不良反应情况。结果 A组的有效率(RR)为90.0%,B组为65.0%(P<0.05),两组不良反应无明显差异。结论热疗联合局部化疗治疗卵巢癌引起恶性腹水治疗优于单纯腹腔灌注紫杉醇局部化疗。
作者 刘丹 王嵬
机构地区 锦州市中心医院
出处 《中国医药指南》 2015年第7期75-75,共1页 Guide of China Medicine
关键词 卵巢癌恶性腹水 局部化疗 体外高频热疗
分类号 R737.31 [医药卫生—肿瘤]
  • 相关文献

参考文献4

二级参考文献46

  • 1沈铿.复发性卵巢癌的诊断和治疗策略[J].现代妇产科进展,2005,14(3):177-180. 被引量：34
  • 2巴彩霞,王亚兰,韩爱玲,李丽清,云文秀.卡铂腹腔灌注联合多西紫杉醇全身化疗双途径治疗晚期卵巢癌[J].临床肿瘤学杂志,2007,12(2):140-141. 被引量：10
  • 3张天泽,徐光炜.肿瘤学[M].2版.沈阳:辽宁科技出版社,2005:1740-1746.
  • 4JAABACK K, JOHNSON N. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer [ J]. Cochrane Database Syst Rev ,2006,25 ( 1 ) :5340-5344.
  • 5周际昌,孙燕,储大同,等.实用肿瘤内科学[M].5A.北京:人民卫生出版社,2005:543.
  • 6Rustin GJ,vander Burg ME,Griffin CL,et al.Early versusdelayed treatment of relapsed ovarian cancer(MRCOV05/EORTC 55955):a randomised trial.[J]Lancet,2010,376(9747):1155-1163.
  • 7Fleming ND,Cass I,Walsh CS,et al.CA125 surveillanceincreases optimal resectability at secondary cytoreductivesurgery for recurrent epithelial ovarian cancer[J].GynecolOncol,2011,121(2):249-252.
  • 8Galaal K,Naik R,Bristow RE,et al.Cytoreductive surgeryplus chemotherapy versus chemotherapy alone for recur-rent epithelial ovarian cancer[J].Cochrane Database SystRev,2010,16(6):CD007822.
  • 9Chi DS,McCaughty K,Diaz JP,et al.Guidelines and se-lection criteria for secondary cytoreductive surgery in pa-tients with recurrent,platinum-sensitive epithelial ovariancarcinoma[J].Cancer,2006,106(9):1933-1939.
  • 10Alberts DS,Liu PY,Wilczynski SP,et al.Randomized trialof pegylated liposomal doxorubicin(PLD)plus carbopla-tin versus carboplatin in platinum-sensitive(PS)patientswith recurrent epithelial ovarian or peritoneal carcinomaafter failure of initial platinum-based chemotherapy(Southwest Oncology Group Protocol S0200)[J].GynecolOncol,2008,108(1):90-94.

共引文献74

同被引文献51

  • 1李秋琳,向旭东,李高峰.恩度与顺铂治疗肺癌恶性血性胸水的有效性与安全性[J].世界临床医学,2017,11(8):11-12. 被引量：2
  • 2冯莉,刘巍,洪雷,吕雅蕾,王玉栋,左静,王龙,韩晶,单玉洁.化疗联合局部热疗治疗晚期胃癌疗效与安全性的Meta分析[J].转化医学杂志,2014,3(2):84-87. 被引量：7
  • 3Santambrogio R, Costa M, Barabino M,et al. Recurrent thepatocellular carcinoma successfully treated with laparo-scopic thermal ablation [J]. Surg Endosc,2012,26 (4);1108-1115.
  • 4Ricd M,Potzger T, Braune N,et al. Cytoreductive surgeryand hyperthermic intrathoracic c hemotherapy pet fusionfor malignant pleural tttmours : perioperative managementandclinical experience [J]. Eur J Cardiothorac Surg,2013,43(4):801-807.
  • 5Saeki H,Ohga T,Ito S,et al. Evaluation of multi-modali-ty treatment for the patients with advan ced esophagealcancer [J]. Fukuoka Igaku Zasshi, 2002,93(12) ; 259-265.
  • 6Deng N’Goh LK,Wang H,et al. A comprehensive surveyofgenomic alterations in gastric cancer reveals systematicpatterns of molecular exclusivity and co -occurrence a-mong distinct therapeutic targets [J]. Gut,2012,61 (5):673-684.
  • 7Bang YJ,Van Cutsem E,Feyereislova A,et al. Trastuzum-ab in combination with chemotherapy versus chemothera-py alone for treatment of HER2-positive advanced gas-tric or gastro -oesophageal junction cancer (ToGA) :aphase 3,open -label,randomized controlled trial [J].Lancet,2010,376(9742) :687-697.
  • 8Oshima Y,Tanaka H, Myrakami H. Laparinib sensitivi-ties of two novel trastuzumab-resistant HER-2 geneam-plified gastric cancer cell lines [J]. Gastric Cancer, 2013,30⑶:1087-1093.
  • 9Bystricky B, Okines AF,Cunningham D. Optimal thera-peutic strategies for respectable oesophageal or oesoph a-gogastric junction cancer [J]. Drugs,2011,71 (5) :541-555.
  • 10Gwyneth L. Why Mother Die 1997-1999: The confiden-tial enquiries into maternal deaths in the Unites King-dom [M]. London:RCOG Press,2001:49-71.

引证文献4

二级引证文献24

中国医药指南
2015年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部